Trans-pralsetinib
CAS: 2097132-93-7
Rif. 3D-XID13293
| 5mg | Prezzo su richiesta | |
| 10mg | Prezzo su richiesta | |
| 25mg | Prezzo su richiesta | |
| 50mg | Prezzo su richiesta | |
| 100mg | Prezzo su richiesta |
Informazioni sul prodotto
Trans-pralsetinib is a macrocyclic compound with a platinum-based chemotherapy. It is an inhibitor of cyclin-dependent kinases CDK4 and CDK6 and inhibits the phosphorylation of these proteins, which prevents cell cycle progression. Trans-pralsetinib has been shown to be effective in treating solid tumours such as lung cancer and pancreatic cancer. The drug has also been observed to have pharmacokinetic properties that are similar to those of sorafenib, another drug used for cancer treatment. Trans-pralsetinib can be detected in biological samples at levels equivalent to those found in plasma after oral administration of 10mg/kg doses. This drug was well tolerated in Phase I clinical trials, with the most common side effects being gastrointestinal disorders (nausea, vomiting) and skin lesions.
Proprietà chimiche
Richiesta tecnica su: 3D-XID13293 Trans-pralsetinib
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
